Stock Events

Stock Events

Pliant Therapeutics 

€0.9905
68
+€0.02+1.8% 18:14 Today

Statistics

Day High
0.9905
Day Low
0.976
52W High
1.56
52W Low
0.921
Volume
1,200
Avg. Volume
0
Mkt Cap
61.33M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q1 2026
Q2 2026
Next
-0.33
-0.31
-0.29
-0.27
Expected EPS
-0.32822004264
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-131.15MNet Income

Analyst Ratings

2.28Average Price Target
The highest estimate is 2.28.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 9PT.MU. It's not an investment recommendation.
NVIDIA
12
NVDA
Microsoft
10
MSFT
Amazon
10
AMZN
Apple
9
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Madrigal Pharmaceuticals
MDGL
Mkt Cap12.33B
Madrigal Pharmaceuticals is involved in the development of therapies for nonalcoholic steatohepatitis (NASH), a type of fibrosis, positioning it as a competitor.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences has a strong portfolio in liver diseases, including fibrosis and NASH, making it a direct competitor in the fibrosis treatment market.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals is developing treatments for cystic fibrosis, competing with Pliant in the broader fibrosis treatment market.
Incyte
INCY
Mkt Cap25.21B
Incyte Corporation works on various therapeutics, including those for fibrotic diseases, positioning it as a competitor in the fibrosis space.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie has a diverse portfolio that includes treatments for fibrotic diseases, making it a competitor in the fibrosis and inflammation market.

About

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Show more...
CEO
Bernard Coulie
Employees
49
Country
United States
ISIN
US7291391057
WKN
000A2P4YV

Listings

STU
DE
9PT.STU
MU
DE
9PT.MU
XNAS
US
PLRX
F
DE
9PT.F

0 Comments

Share your thoughts

FAQ

What is Pliant Therapeutics stock price today?▼
The current price of 9PT.MU is €0.99 EUR — it has increased by +1.8% in the past 24 hours. Watch Pliant Therapeutics stock price performance more closely on the chart.
What is Pliant Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Pliant Therapeutics stocks are traded under the ticker 9PT.MU.
Is Pliant Therapeutics stock price growing?▼
9PT.MU stock has fallen by -1.34% compared to the previous week, the month change is a +6.45% rise, over the last year Pliant Therapeutics has showed a -29.75% decrease.
What is Pliant Therapeutics market cap?▼
Today Pliant Therapeutics has the market capitalization of 61.33M
When is the next Pliant Therapeutics earnings date?▼
Pliant Therapeutics is going to release the next earnings report on November 05, 2026.
What were Pliant Therapeutics earnings last quarter?▼
9PT.MU earnings for the last quarter are -0.31 EUR per share, whereas the estimation was -0.3 EUR resulting in a -5.33% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Pliant Therapeutics revenue for the last year?▼
Pliant Therapeutics revenue for the last year amounts to 0 EUR.
What is Pliant Therapeutics net income for the last year?▼
9PT.MU net income for the last year is -131.15M EUR.
How many employees does Pliant Therapeutics have?▼
As of September 03, 2026, the company has 49 employees.
In which sector is Pliant Therapeutics located?▼
Pliant Therapeutics operates in the Health & Wellness sector.
When did Pliant Therapeutics complete a stock split?▼
Pliant Therapeutics has not had any recent stock splits.
Where is Pliant Therapeutics headquartered?▼
Pliant Therapeutics is headquartered in SOUTH SAN FRANCISCO, United States.